GlaxoSmithKline Pharmaceuticals Limited — Updates, 07-03-2026: General Updates
07-03-2026 | 05:34 pm
07-03-2026 | 05:34 pm
GSK Pharma seeks shareholder approval for appointing Ronojit Biswas as Whole-time Director & CFO. His remuneration includes an annual basic salary up to 1.92 Cr, performance bonus up to 100% of basic, and a 0.20 Cr sign-on bonus. This strengthens leadership.
No comments yet. Be the first to comment!
All announcements from GlaxoSmithKline Pharmaceuticals Limited
